{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:58:43Z","timestamp":1791388723838,"version":"4.3.3"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.jaci.2011.08.022","type":"journal-article","created":{"date-parts":[[2011,9,23]],"date-time":"2011-09-23T15:11:16Z","timestamp":1316790676000},"page":"1100-1106.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Beryllium-specific CD4+ T cells in blood as a biomarker of disease progression"],"prefix":"10.1016","volume":"128","author":[{"given":"Allison K.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas G.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Falta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"Mroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee S.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Fontenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2011.08.022_bib1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.it.2005.08.004","article-title":"Genetic susceptibility and immune-mediated destruction in beryllium-induced disease","volume":"26","author":"Fontenot","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2011.08.022_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1097-0274(199607)30:1<16::AID-AJIM3>3.0.CO;2-Q","article-title":"Machining risk of beryllium disease and sensitization with median exposures below 2 mg\/m3","volume":"30","author":"Kreiss","year":"1996","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.jaci.2011.08.022_bib3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/ajrccm\/148.4_Pt_1.985","article-title":"Epidemiology of beryllium sensitization and disease in nuclear workers","volume":"148","author":"Kreiss","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2011.08.022_bib4","first-page":"267","article-title":"Beryllium disease screening in the ceramics industry: blood test performance and exposure-disease relations","volume":"35","author":"Kreiss","year":"1993","journal-title":"J Occup Med"},{"key":"10.1016\/j.jaci.2011.08.022_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.8105536","article-title":"HLA-DPB1 glutamate 69: a genetic marker of beryllium disease","volume":"262","author":"Richeldi","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.jaci.2011.08.022_bib6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.7326\/0003-4819-108-5-687","article-title":"Proliferative response of bronchoalveolar lymphocytes to beryllium","volume":"108","author":"Rossman","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2011.08.022_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0091-6749(91)90300-D","article-title":"Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease","volume":"88","author":"Mroz","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.08.022_bib8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1164\/rccm.200402-190OC","article-title":"Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk","volume":"171","author":"Newman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2011.08.022_bib9","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jaci.2005.01.019","article-title":"Frequency of beryllium-specific, TH1-type cytokine-expressing CD4+ T cells in patients with beryllium-induced disease","volume":"115","author":"Pott","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.08.022_bib10","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1172\/JCI24908","article-title":"Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response","volume":"115","author":"Fontenot","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2011.08.022_bib11","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.4049\/jimmunol.180.4.2704","article-title":"Up-regulation of programmed death-1 expression on beryllium-specific CD4+ T cells in chronic beryllium disease","volume":"180","author":"Palmer","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2011.08.022_bib12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00043764-200103000-00012","article-title":"Beryllium particulate exposure and disease relations in a beryllium machining plant","volume":"43","author":"Kelleher","year":"2001","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.jaci.2011.08.022_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00043764-200103000-00011","article-title":"Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant","volume":"43","author":"Newman","year":"2001","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.jaci.2011.08.022_bib14","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1164\/ajrccm\/139.6.1479","article-title":"Pathologic and immunologic alterations in early stages of beryllium disease: re-examination of disease definition and natural history","volume":"139","author":"Newman","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2011.08.022_bib15","first-page":"953","article-title":"Significance of the blood beryllium lymphocyte proliferation test","volume":"104","author":"Newman","year":"1996","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.jaci.2011.08.022_bib16","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1164\/rccm.201001-0025OC","article-title":"Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects","volume":"181","author":"Mack","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2011.08.022_bib17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1165\/ajrcmb.18.4.2981","article-title":"Expansions of T-cell subsets expressing particular T cell receptor variable regions in chronic beryllium disease","volume":"18","author":"Fontenot","year":"1998","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2011.08.022_bib18","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.4049\/jimmunol.163.2.1019","article-title":"Identification of pathogenic T cells in patients with beryllium-induced lung disease","volume":"163","author":"Fontenot","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2011.08.022_bib19","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1172\/JCI0215846","article-title":"Target organ localization of memory CD4+ T cells in patients with chronic beryllium disease","volume":"110","author":"Fontenot","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2011.08.022_bib20","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1172\/JCI200318317","article-title":"CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cells","volume":"112","author":"Fontenot","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2011.08.022_bib21","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/ajrccm.165.6.2104002","article-title":"Human leukocyte antigen class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity","volume":"165","author":"Rossman","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2011.08.022_bib22","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.4049\/jimmunol.171.12.6910","article-title":"Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease","volume":"171","author":"Maier","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2011.08.022_bib23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jaci.2007.03.009","article-title":"CD57 expression correlates with alveolitis severity in subjects with beryllium-induced disease","volume":"120","author":"Palmer","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.08.022_bib24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1074-7613(00)80656-1","article-title":"HIV-induced immunopathogenesis","volume":"9","author":"Shearer","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2011.08.022_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s004200100237","article-title":"Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant","volume":"74","author":"Henneberger","year":"2001","journal-title":"Int Arch Occup Environ Health"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911013236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911013236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:29:08Z","timestamp":1758788948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674911013236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0091674911013236"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2011.08.022","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beryllium-specific CD4+ T cells in blood as a biomarker of disease progression","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2011.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}